1-3 of 3
Sherrie Perkins
Close
Sort by
Journal Articles

BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: a report from the Children's Oncology Group

Clinical Trials & Observations
Kara M. Kelly, Richard Sposto, Raymond Hutchinson, Vickie Massey, Kathleen McCarten, Sherrie Perkins, Mark Lones, Doojduen Villaluna, Michael Weiner
Journal: Blood
Blood (2011) 117 (9): 2596–2603.
https://doi.org/10.1182/blood-2010-05-285379
Published: 2011
Journal Articles

Results of CCG-5941: Intensified Multiagent Chemotherapy and Non-Cross Resistant Maintenance Therapy for Advanced Lymphoblastic Lymphoma in Children and Adolescents.

Minnie Abromowitch, MD, Richard Sposto, PhD, Sherrie Perkins, MD,PhD, Jonathan Finlay, MD, Mitchell S. Cairo, MD
Journal: Blood
Blood (2006) 108 (11): 533.
https://doi.org/10.1182/blood.V108.11.533.533
Published: 2006
Journal Articles

In Pediatric Mature B-Cell Non Hodgkin Lymphoma (NHL), Complex Karyotype or del(13q) Are Linked Prognostic Factors in Burkitt Lymphoma (BL) While 8q24/c-myc Rearrangement Is Associated with a Strong Adverse Effect in Diffuse Large B-Cell Lymphoma (DLBCL).

Hélène A. Poirel, Nyla A. Heerema, John Swansbury, Anne Aupérin, Erika Launay, Warren G. Sanger, Polly Talley, Martine Raphael, Sherrie Perkins, Keith McCarthy, Richard Sposto, Claire Weston, Mary Gerrard, Mitch S. Cairo, Alain Bernheim, Catherine Patte
Journal: Blood
Blood (2005) 106 (11): 1905.
https://doi.org/10.1182/blood.V106.11.1905.1905
Published: 2005